Roche (OTCMKTS:RHHBY) Raised to “Hold” at Zacks Research

Roche (OTCMKTS:RHHBY) was upgraded by research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report issued on Monday,Zacks.com reports.

A number of other research firms have also recently commented on RHHBY. Morgan Stanley upgraded shares of Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 price target for the company in a report on Friday, August 7th. HSBC lowered shares of Roche from a “buy” rating to a “hold” rating in a report on Monday, July 6th. Five analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $60.00.

Roche Trading Up 1.7%

OTCMKTS:RHHBY opened at $58.47 on Monday. The company has a current ratio of 1.38, a quick ratio of 1.12 and a debt-to-equity ratio of 0.72. Roche has a twelve month low of $39.50 and a twelve month high of $60.85. The company has a fifty day moving average of $53.58 and a 200-day moving average of $52.95.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in RHHBY. Puzo Michael J bought a new stake in Roche during the 2nd quarter worth approximately $1,229,000. S&CO Inc. lifted its holdings in shares of Roche by 163.0% in the first quarter. S&CO Inc. now owns 140,551 shares of the company’s stock valued at $6,880,000 after purchasing an additional 87,107 shares in the last quarter. Opal Capital LLC purchased a new position in shares of Roche during the first quarter valued at approximately $4,448,000. Hantz Financial Services Inc. raised its position in Roche by 164.9% in the 4th quarter. Hantz Financial Services Inc. now owns 79,732 shares of the company’s stock valued at $4,112,000 after buying an additional 49,633 shares during the last quarter. Finally, Enterprise Financial Services Corp lifted its stake in Roche by 6.6% during the 1st quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock valued at $277,000 after acquiring an additional 345 shares in the last quarter.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.